Serotonin Influences Insulin Secretion in Rat Insulinoma INS-1E Cells

Yeong-Min Yoo,Seong Soo Joo

DOI: https://doi.org/10.3390/ijms25136828

IF: 5.6

2024-06-22

International Journal of Molecular Sciences

Abstract:Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine that plays a critical role in insulin secretion, energy metabolism, and mitochondrial biogenesis. However, the action of serotonin in insulin production and secretion by pancreatic β cells has not yet been elucidated. Here, we investigated how exogenous nanomolar serotonin concentrations regulate insulin synthesis and secretion in rat insulinoma INS-1E cells. Nanomolar serotonin concentrations (10 and 50 nM) significantly increased insulin protein expression above the constant levels in untreated control cells and decreased insulin protein levels in the media. The reductions in insulin protein levels in the media may be associated with ubiquitin-mediated protein degradation. The levels of membrane vesicle trafficking-related proteins including Rab5, Rab3A, syntaxin6, clathrin, and EEA1 proteins were significantly decreased by serotonin treatment compared to the untreated control cells, whereas the expressions of Rab27A, GOPC, and p-caveolin-1 proteins were significantly reduced by serotonin treatment. In this condition, serotonin receptors, Gαq-coupled 5-HT2b receptor (Htr2b), and ligand-gated ion channel receptor Htr3a were significantly decreased by serotonin treatment. To confirm the serotonylation of Rab3A and Rab27A during insulin secretion, we investigated the protein levels of Rab3A and Rab27A, in which transglutaminase 2 (TGase2) serotonylated Rab3A but not Rab27A. The increases in ERK phosphorylation levels were consistent with increases in the expression of p-Akt. Also, the expression level of the Bcl-2 protein was significantly increased by 50 and 100 nM serotonin treatment compared to the untreated control cells, whereas the levels of Cu/Zn-SOD and Mn-SOD proteins decreased. These results indicate that nanomolar serotonin treatment regulates the insulin protein level but decreases this level in media through membrane vesicle trafficking-related proteins (Rab5, Rab3A, syntaxin6, clathrin, and EEA1), the Akt/ERK pathway, and Htr2b/Htr3a in INS-1E cells.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The paper primarily explores the effects of serotonin (5-hydroxytryptamine, 5-HT) on insulin synthesis and secretion in pancreatic β-cells and its related mechanisms. The study observes the impact of nanomolar concentrations of exogenous serotonin on insulin protein expression and secretion in rat insulinoma INS-1E cells.

The main findings include:
1. Nanomolar levels of serotonin (10 and 50 nM) significantly increased the expression of insulin protein within INS-1E cells but decreased the insulin protein levels in the cell culture medium. This reduction may be related to ubiquitin-mediated protein degradation.
2. After serotonin treatment, the levels of various proteins involved in vesicle transport (such as Rab5, Rab3A, syntaxin 6, clathrin, and EEA1) significantly decreased, while the expression of Rab27A, GOPC, and phosphorylated caveolin-1 proteins increased.
3. Serotonin receptors Htr2b and Htr3a significantly decreased after serotonin treatment, whereas the Htr1d receptor showed an initial increase followed by a decrease.
4. In the presence of serotonin, the small GTPase Rab3A underwent serotonylation, while Rab27A did not.
5. Serotonin treatment also led to increased phosphorylation levels of ERK and Akt, and the expression level of Bcl-2 protein significantly increased after treatment with 50 and 100 nM serotonin, while the levels of antioxidant enzymes Cu/Zn-SOD and Mn-SOD decreased.

In summary, the study reveals that serotonin affects insulin protein levels and secretion by regulating vesicle transport-related proteins, serotonin receptors, and the Akt/ERK signaling pathway in pancreatic β-cells. These results contribute to a better understanding of the role of serotonin in the regulation of insulin secretion.